CN Patent
CN111789808A — 口服医药组成物及其结构
Assigned to Standard Chemical and Pharmaceutical Corp Ltd · Expires 2020-10-20 · 6y expired
What this patent protects
本发明有关于一种口服医药组成物及其结构,其为将酸不稳定性生理活性成分与碱性氨基酸分设于不同层,藉此改善酸不稳定性生理活性成分引起储存稳定性不佳的问题。
USPTO Abstract
本发明有关于一种口服医药组成物及其结构,其为将酸不稳定性生理活性成分与碱性氨基酸分设于不同层,藉此改善酸不稳定性生理活性成分引起储存稳定性不佳的问题。
Drugs covered by this patent
- Dexilant (DEXLANSOPRAZOLE) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.